# VEGF signaling in Mammary Tumorigenesis

> **NIH NIH R01** · UNIV OF MASSACHUSETTS MED SCH WORCESTER · 2021 · $397,813

## Abstract

This proposal will examine the unanticipated hypothesis that the α6β4 integrin (referred to as `β4') contributes
to the initiation and metastasis of breast tumors by a non-cell autonomous mechanism. This hypothesis
derives from the observations that the expression of β4 is low or absent in breast cancer stem cells (CSCs) but
that it contributes to the formation and metastasis of breast cancers. A major goal of this proposal is to
reconcile these discrepant observations and understand how β4 contributes to tumor formation and metastasis.
Interestingly, triple-negative breast cancers (TNBCs) contain a distinct sub-population of cells characterized by
high expression of the β4 integrin (β4high) that is distinct from CSCs (β4-/low/CD24low/CD44high), exhibits basal
epithelial differentiation and lacks stem cell properties. These observations indicate that repression of β4 is
necessary for CSC function. In fact, we observed unexpectedly that β4 expression in CSCs promotes their
differentiation and inhibits their self-renewal. The first specific aim will investigate the mechanism that
underlies this phenomenon and it will focus on the exciting possibility that it involves the ability of β4 to
modulate focal adhesions and cytoskeletal tension resulting in diminished stem cell properties. This aim will
also test the possibility that alterations in cytoskeletal tension have a causal role in promoting the differentiation
of CSCs.
The second specific aim will evaluate the hypothesis that the β4high sub-population exerts non-cell autonomous
regulation of CSCs. In other terms, a key function of the β4high subpopulation is to expand the CSC population.
More specifically, it is proposed that this distinct sub-population engages in paracrine signaling with CSCs
mediated by parathyroid hormone-related protein (PTHrP) and that this signaling contributes to the expansion
of CSCs. This hypothesis is based on the observations that β4 regulates PTHrP expression and that the β4high
sub-population and CSCs are in proximity in breast tumors. Also, our preliminary data indicate that the β4high
sub-population helps to maintain self-renewal and survival. These observations provide an explanation for
how the β4 integrin contributes to tumor initiation and metastasis without being expressed in CSCs.
The final specific aim will study the relationship between CSCs and β4high cells in vivo and evaluate their
relative contribution to tumor initiation and metastasis. The first set of experiments will examine whether both
CSCs and β4high cells are required for efficient tumor formation and metastasis using a transgenic model of
TNBC. The second sub-aim probe more deeply into the relationship between CSCs and β4high cells by
evaluating the extent to which CSCs differentiate in vivo and assessing their association with β4high cells in
niches. These goals will be facilitated by the use of reporter constructs to tag these distinct populations. This
approach will allow us to address seve...

## Key facts

- **NIH application ID:** 10152521
- **Project number:** 5R01CA168464-10
- **Recipient organization:** UNIV OF MASSACHUSETTS MED SCH WORCESTER
- **Principal Investigator:** Arthur M Mercurio
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $397,813
- **Award type:** 5
- **Project period:** 2012-07-09 → 2023-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10152521

## Citation

> US National Institutes of Health, RePORTER application 10152521, VEGF signaling in Mammary Tumorigenesis (5R01CA168464-10). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10152521. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*